Medicure (OTCMKTS:MCUJF) Announces Earnings Results

Medicure (OTCMKTS:MCUJF) posted its earnings results on Wednesday. The company reported ($0.09) earnings per share (EPS) for the quarter, Zacks reports. The business had revenue of $5.93 million for the quarter. Medicure had a negative return on equity of 6.65% and a negative net margin of 5.70%.

Medicure Stock Down 0.5%

Shares of MCUJF stock opened at $0.95 on Friday. The firm has a fifty day moving average of $0.82 and a 200-day moving average of $0.82. The company has a quick ratio of 1.06, a current ratio of 1.48 and a debt-to-equity ratio of 0.03. Medicure has a 12-month low of $0.44 and a 12-month high of $0.97. The company has a market capitalization of $9.88 million, a price-to-earnings ratio of -9.47 and a beta of 1.04.

About Medicure

Medicure Inc, a biopharmaceutical company, engages in the research, development, and commercialization of human therapies for the cardiovascular market. The company markets and distributes AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction.